Characteristics of azole-resistant Aspergillus fumigatus attached to agricultural products imported to Japan.

[1]  M. Tashiro,et al.  Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  D. Hagiwara,et al.  Non-cyp51A Azole-Resistant Aspergillus fumigatus Isolates with Mutation in HMG-CoA Reductase , 2018, Emerging infectious diseases.

[3]  A. Chowdhary,et al.  Triazole resistance surveillance in Aspergillus fumigatus. , 2018, Medical mycology.

[4]  Brendan R. Jackson,et al.  Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States , 2018, Emerging infectious diseases.

[5]  D. Hagiwara,et al.  First clinical isolation report of azole-resistant Aspergillus fumigatus with TR34/L98H-type mutation in Japan. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[6]  J. Meis,et al.  Intercountry Transfer of Triazole-Resistant Aspergillus fumigatus on Plant Bulbs , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  B. Zwaan,et al.  A Novel Environmental Azole Resistance Mutation in Aspergillus fumigatus and a Possible Role of Sexual Reproduction in Its Emergence , 2017, mBio.

[8]  P. Le Pape,et al.  Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia , 2017, Scientific Reports.

[9]  A. Chowdhary,et al.  Global Population Genetic Analysis of Aspergillus fumigatus , 2017, mSphere.

[10]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  D. Hagiwara,et al.  Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46/Y121F/T289A isolated in Japan. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[12]  Catherine Beigelman-Aubry,et al.  Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management , 2015, European Respiratory Journal.

[13]  W. Melchers,et al.  Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  D. Denning,et al.  The clinical spectrum of pulmonary aspergillosis , 2014, Thorax.

[15]  T. Nishino,et al.  Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus , 2012, Antimicrobial Agents and Chemotherapy.

[16]  T. Nishino,et al.  Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan , 2011, Antimicrobial Agents and Chemotherapy.

[17]  W. Melchers,et al.  Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology Modeling , 2010, Antimicrobial Agents and Chemotherapy.

[18]  J. Mouton,et al.  Use of a Novel Panel of Nine Short Tandem Repeats for Exact and High-Resolution Fingerprinting of Aspergillus fumigatus Isolates , 2005, Journal of Clinical Microbiology.

[19]  D. Hagiwara,et al.  Azole-resistant Aspergillus fumigatus Containing a 34-bp Tandem Repeat in cyp51A Promoter is Isolated from the Environment in Japan. , 2017, Medical mycology journal.